Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.

[1]  T. To,et al.  Is carcinoma in situ a precursor lesion of invasive breast cancer? , 2014, International journal of cancer.

[2]  V. Sondak,et al.  Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Metastasis Among Young and Old Patients , 2014, Annals of Surgical Oncology.

[3]  J. Moan,et al.  Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients , 2012, Melanoma research.

[4]  Arnold J Stromberg,et al.  Clinicopathologic and Survival Differences between Upper and Lower Extremity Melanomas , 2012, The American surgeon.

[5]  C. Shea,et al.  Lentigo maligna: melanoma in situ on chronically sun-damaged skin. , 2011, Archives of pathology & laboratory medicine.

[6]  J. Coebergh,et al.  Gender differences in melanoma survival: female patients have a decreased risk of metastasis. , 2011, The Journal of investigative dermatology.

[7]  Samit R. Joshi,et al.  Aging of the innate immune system. , 2010, Current opinion in immunology.

[8]  M. Driscoll,et al.  Melanoma epidemic: Facts and controversies. , 2010, Clinics in dermatology.

[9]  A. Gavin,et al.  Cutaneous melanoma mortality starting to change: a study of trends in Northern Ireland. , 2009, European journal of cancer.

[10]  Myles G Cockburn,et al.  Increasing burden of melanoma in the United States. , 2009, The Journal of investigative dermatology.

[11]  E. Grimm,et al.  Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma. , 2009, The Journal of investigative dermatology.

[12]  P. Rosenberg,et al.  Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Therese Miller,et al.  Screening for Skin Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[14]  M. Tucker,et al.  Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. , 2008, The Journal of investigative dermatology.

[15]  E. Herrera‐Ceballos,et al.  Thick melanoma: the problem continues , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  M. Pollán,et al.  Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women , 2008, The British journal of dermatology.

[17]  D. Moore,et al.  Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. , 2006, Journal of the American Academy of Dermatology.

[18]  D. Whiteman,et al.  Anatomic site, sun exposure, and risk of cutaneous melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Aitken,et al.  Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 , 2006, Cancer Causes & Control.

[20]  J. Boldrick,et al.  Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. , 2005, The Journal of investigative dermatology.

[21]  G. Colditz,et al.  Risk Factors for Melanoma by Body Site , 2005, Cancer Epidemiology Biomarkers & Prevention.

[22]  D. Stockton,et al.  Thick melanoma: the challenge persists , 2005, The British journal of dermatology.

[23]  A. Stromberg,et al.  Correlation Between Prognostic Factors and Increasing Age in Melanoma , 2004, Annals of Surgical Oncology.

[24]  Ajay N. Jain,et al.  Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.

[25]  E. Feuer,et al.  Impact of reporting delay and reporting error on cancer incidence rates and trends. , 2002, Journal of the National Cancer Institute.

[26]  C. Douglass,et al.  Validation of self-reported periodontal measures among health professionals. , 2002, Journal of public health dentistry.

[27]  C. Garbe,et al.  Time trends of cutaneous melanoma in Queensland, Australia and Central Europe , 2000, Cancer.

[28]  A. Jemal,et al.  Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. , 2000, Journal of the National Cancer Institute.

[29]  D. Whiteman,et al.  Determinants of melanocyte density in adult human skin , 1999, Archives of Dermatological Research.

[30]  J. Hunter,et al.  Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94 , 1997, BMJ.

[31]  L. Akslen,et al.  Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma , 1997, International journal of cancer.

[32]  R. H. Johr,et al.  Lentigo maligna and lentigo maligna melanoma. , 1997, Journal of the American Academy of Dermatology.

[33]  R. Swerlick,et al.  The melanoma epidemic: more apparent than real? , 1997, Mayo Clinic proceedings.

[34]  A. Kopf,et al.  The incidence of malignant melanoma in the United States: issues as we approach the 21st century. , 1996, Journal of the American Academy of Dermatology.

[35]  L. Garfinkel,et al.  Occupation and the risk of malignant melanoma , 1995 .

[36]  A. Biggeri,et al.  Incidence of cutaneous melanoma in the centre of Italy: anatomic site distribution, histologic types and thickness of tumour invasion in a registry-based study , 1994, Melanoma research.

[37]  Gary Lyman,et al.  Age as a prognostic factor in the malignant melanoma population , 1994, Annals of Surgical Oncology.

[38]  H. Seigler,et al.  Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. , 1994, Archives of surgery.

[39]  A. Green,et al.  A theory of site distribution of melanomas: Queensland, Australia , 1992, Cancer Causes & Control.

[40]  N. Martin,et al.  Increasing incidence of cutaneous melanoma in Queensland, Australia. , 1992, Journal of the National Cancer Institute.

[41]  R. Hiatt,et al.  The possible effect of increased surveillance on the incidence of malignant melanoma. , 1986, Preventive medicine.

[42]  W. Willett,et al.  Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. , 1986, American journal of epidemiology.

[43]  J. Hunter,et al.  Cutaneous malignant melanoma in Scotland. , 1982, British Journal of Cancer.

[44]  V. McGovern,et al.  Malignant melanoma: Influence of site of lesion and age of patient in the female superiority in survival , 1980, Cancer.

[45]  M C Mihm,et al.  Early detection of primary cutaneous malignant melanoma. A color atlas. , 1973, The New England journal of medicine.

[46]  J. Aitken,et al.  Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990–2006 , 2012, International journal of cancer.

[47]  Susun Bellew,et al.  Melanoma Thickness Trends in the United States, 1988–2006 , 2011 .

[48]  G. Colditz,et al.  Risk Factors for Melanoma by Body Site for Whites , 2005 .

[49]  F. Pontén,et al.  Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden, 1968-1992. , 1998, Cancer detection and prevention.

[50]  R. Swerlick,et al.  The melanoma epidemic. Is increased surveillance the solution or the problem? , 1996, Archives of dermatology.